In vitro factors affecting the concentration of gamma-LpE (γ-LpE) in human plasma

Journal of Lipid Research

Volumn 39, Issue 4, 1998, Pages 861-872

  Krimbou, Larbi ^a   Tremblay, Michel ^a   Jacques, Hélène ^a   Davignon, Jean ^a   Cohn, Jeffrey S ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

ApoE; Cholesterol efflux; HDL

Indexed keywords

APOLIPOPROTEIN E; LIPOPROTEIN; POLYCLONAL ANTIBODY; SPHINGOMYELIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD STORAGE; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; DIMERIZATION; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; IMMUNOBLOTTING; LIPOPROTEIN BLOOD LEVEL; MALE; PARTICLE SIZE; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POSTPRANDIAL STATE; PRIORITY JOURNAL; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; APOLIPOPROTEINS E; ARTIFACTS; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHROMATOGRAPHY, GEL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GLYCOPROTEINS; HUMANS; HYPERTRIGLYCERIDEMIA; LIPIDS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; PHENOTYPE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; SPECIMEN HANDLING;

EID: 0031977394     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Mahley, R. W. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240: 622-630.
2. Mazzone, T. 1996. Apolipoprotein E secretion by macrophages: its potential physiological functions. Curr. Opin. Lipidol. 7: 303-307.
3. Zhang, S. H., R. L. Reddick, J. A. Pierdrahita, and N. Maeda. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258: 468-471.
4. Plump, A. S., J. D. Smith, T. Hayek, K. Aalto-Setala, A. Walsh, J. G. Verstuyft, E. M. Rubin, and J. L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination of ES cells. Cells. 71: 343-353.
5. Linton, M. F., J. B. Atkinson, and S. Fazio. 1995. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science. 267: 1034-1037.
6. Boisvert, W. A., J. Spangenberg, and L. K. Curtiss. 1995. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. J. Clin. Invest. 96: 1118-1124.
7. Bellosta, S., R. W. Mahley, D. A. Sanan, J. Murata, D. L. Newland, J. M. Taylor, and R. E. Pitas. 1995. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J. Clin. Invest. 96: 2170-2179.
8. Castro, G. R., and C. J. Fielding. 1984. Evidence for the distribution of apolipoprotein E between lipoprotein classes in human normocholesterolemic plasma and for the origin of unassociated apolipoprotein E (Lp-E). J. Lipid Res. 25: 58-67.
9. Huang, Y., A. von Eckardstein, S. Wu, N. Maeda, and G. Assmann. 1994. A plasma lipoprotein containing only apolipoprotein E and with γ mobility on electrophoresis releases cholesterol from cells. Proc. Natl. Acad. Sci. USA. 91: 1834-1838.
10. Huang, Y., A. von Eckardstein, S. Wu, and G. Assmann. 1995. Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma. J. Clin. Invest. 96: 2693-2701.
11. 2-LpE, and α-LpE. J. Lipid Res. 38: 35-48.
12. Tall, A. R. 1990. Plasma high-density lipoproteins: metabolism and relationship to atherogenesis. J. Clin. Invest. 86: 379-384.
13. von Eckardstein, A., Y. Huang, and G. Assmann. 1994. Physiological role and clinical significance of high-density lipoprotein subclasses. Curr. Opin. Lipidol. 5: 404-416.
14. Weisgraber, K. H., and L. H. Shinto. 1991. Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity. J. Biol. Chem. 266: 12029-12034.
15. Salacinski, P. R., C. McLean, J. E. Sykes, V. V. Clement-Jones, and P. J. Lowry. 1981. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha, 6 alpha-diphenyl glycoluril (Lodogen). Anal. Biochem. 117: 136-146.
16. Cohn, J. S., M. Tremblay, M. Amiot, D. Bouthillier, M. Roy, J. Genest, Jr., and J. Davignon. 1996. Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects. Arterioscler. Thromb. Vasc. Biol. 16: 149-159.
17. Ohta, T., S. Hattori, R. Nakamura, S. Horiuchi, J. Frohlich, K. Takata, Y. Ikeda, Y. Saito, and I. Matsuda. 1994. Characterization of subspecies of apolipoprotein A-I-containing lipoprotein in homozygotes for familial lecithin:cholesterol acyltransferase deficiency. Arterioscler. Thromb. 14: 1137-1145.
18. Tato, F., G. L. Vega, A. R. Tall, and S. M. Grundy. 1995. Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 15: 112-120.
19. Chiba, H., K. Akizawa, S-I. Fujisawa, T. Osaka-Nakamori, N. Iwasaki, H. Suzuki, S. Intoh, K. Matsuno, T. Mitamura, and K. Kobayashi. 1992. A rapid and simple quantification of human apolipoprotein E-rich high-density lipoproteins in serum. Biochem. Med. Metab. Biol. 4: 31-37.
20. Hill, J. S., and P. H. Pritchard. 1990. Improved phenotyping of apolipoprotein E: application to population frequency distribution. Clin. Chem. 36: 1871-1874.
21. Helser, C. B., A. R. Tall, T. L. Swenson, P. K. Weech, Y. L. Marcel, and R. W. Milne. 1988. Monoclonal antibodies to the M, 74,000 cholesteryl transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma. J. Biol. Chem. 263: 5020-5023.
22. Francone, O. L., C. J. Fielding, and P. E. Fielding. 1990. Distribution of cell-derived cholesterol among plasma lipoproteins: a comparison of three techniques. J. Lipid. Res. 31: 2195-2200.
23. 1-HDL. Biochim. Biophys. Acta. 1301: 255-262.
24. Miida, T., M. Kawano, C. J. Fielding, and P. E. Fielding. 1992. Regulation of the concentration of preβ high-density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activity. Biochemistry. 31: 11112-11117.
25. Blum, C. B. 1982. Dynamics of apolipoprotein E metabolism in humans. J. Lipid Res. 23: 1308-1316.
26. Ito, H., C. Naito, Y. Suzuki, K. Nakamura, and M. Nagase. 1994. Post-prandial triglyceride-rich lipoprotein metabolism: possible role of sialilated apolipoprotein E isoproteins. Eur. J. Clin. Invest. 24: 468-475.
27. Tam, S. P., and W. C. Breckenridge. 1983. Apolipoprotein and lipid distribution between vesicles and HDL-like particles formed during lipolysis of human very low density lipoproteins by perfused rat heart. J. Lipid Res. 24: 1343-1357.
28. Murdoch, S. J., and W. C. Breckenridge. 1995. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL. Atherosclerosis. 18: 193-212.
29. Assmann, G., H. Schulte, A. von Eckardstein, and Y. Huang. 1996. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis. 124: S11-S20.
30. Weisgraber, K. H. 1990. Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. J. Lipid Res. 31: 1503-1511.
31. Nazih, H., A. T. Remaley, P. Alaupovic, and H. B. Brewer, Jr. 1996. Apolipoprotein E: the differential effect of apoE and LpE particles in cholesterol efflux. Circulation 94: I-520 (abstract).